science

We welcome our new lab members Robin van Brummelen and Pascal Guntern! Great to have you guys on board! 



science

On December 15, 2017 we are organizing the 2nd Type-2 Immunity Meeting Bern. Registration is mandatory and abstract submission is open now. Check out the preliminary program and have a look at the plenary speakers on the T2IMB website. We hope to see you there! 



science

We are happy and very grateful that the Swiss and Bernese "Lungenliga" have decided to support our project on new approaches to treat allergic asthma. These studies will be carried out together with the research group of Prof. Christophe von Garnier. We are looking forward to the collaboration.  

 

science

Our former PhD student Dr. Fabian Zellweger has recently published an original article on the regulation of allergic reactions via CD32b as well as a review article on the latest reports on IgE-related allergic disorders developent. We congratulate him for this great achievement!

 

science

Our PhD student Fabian Zellweger has been awarded an Abstract Prize for his work on the regulation of allergic reactions via CD32b at the 2016 European Academy of Allergy and Clinical Immunology Conference in Vienna. Congratulations! 

 

science

Together with our collaborators Prof. Theodore Jardetzky and Prof. Kari Nadeau from Stanford University we have published an interesting study on the "Structural basis of Omalizumab therapy and Omalizumab-mediated IgE exchange" in Nature Communicaitons. 

 

science

Under the guidance of Prof. Peter M. Villiger our colleagues from the Department of Rheumatology, Immunology and Allergology have published an interesting, phase 2, randomised, double-blind, placebo-controlled study about the use of Tocilizumab for the treatment of giant cell arteritis in The Lancet. We congratulate the authors to this remarkable achievment!!!



science

In a collaboration with the Group of Prof. Trajkovski from the University of Geneva Prof. Sigfried Hapfelmeier from the Institute for Infectious Disease at the University of Bern has lately published two outstanding papers in Nature Medicine and Cell. We congratulate the authors to this remarkable achievment.



science

On December 16, 2015 we are organizing the 1st Type-2 Immunity Meeting Bern. Registration is mandatory and abstract submission is open now. Check out the preliminary program and have a look at the plenary speakers on the T2IMB website. We hope to see you there! 



science

Our Lab Manager Dr. Daniel Brigger has published a first-author paper in "Cell Death & Disease". The study, in which the role of ATRA (all-trans retinoic acid) -induced autophagy in mammary tumors has been investigated, was conducted in the lab of Prof. Mario Tschan at the Institute of Pathology, University of Bern. We congratulate the authors for this interesting piece of work. 

science

Nature Medicine has published a News and Views article written by A. J. Filiano & J. Kipnis about the recent study of Dr. Saul A. Villeda (UCSF) and Prof. Tony Wyss-Coray (Stanford University) to which we also contributed.

In their article entiteled "Breaking bad blood: β2-microglobulin as a pro-aging factor in blood" they state that, "...the burden imposed by age-related diseases is astronomical. Slowing—or even reversing—deleterious age-related processes might delay or prevent the onset of age-related diseases. Identification of molecules, such as B2M, that accelerate the development of these deficits is a promising first step. The fountain of youth may well be flowing in our blood."

Open Positions

Are you interested in becoming the newest member of the Eggel Lab?

readmore

Contact Us

mapUniversity of Bern, Sahlihaus 2
CH-3010 Bern 

map+41 (0)31 632 22 87